Join us March 9th at 12pm at the corner of 6th street and Brazos, for a healthy lunch powered by FTR4H. It will be followed by the exciting program curated by Startup Colors’ team, with inspiring talks, expert and fireside chats and networking sessions covering the following topics:
Visit the website to check all the speakers and the complete program and to reserve your free ticket. Discover with us all colors and shades of innovation in Healthcare during this special day at SXSW 2019 and how we can make a change together!
Kaia is a mobile app addressing back pain by using AI to guide patients through therapy and selected exercises which are moderated through camera observation of the users posture.
air is a smartphone app with a connected spirometer guiding users through spirometry measurements. It is meant to be used either by asthma patients or by physicians during patient examinations.
The winning solution on the competition was iSikCure app, connecting patients to healthcare providers and using a special reward points system creating a new way to pay for health services and encouraging medication adherence.
See all 15 startups pitching at the competition here.
In the pre-competition program different topic on mHealth development were discussed. Ralf-Gordon Jahns presented the latest Research2Guidance research findings on mHealth market. At the moment, the estimated number of mHealth apps is 325,000, with health insurers becoming an increasingly important distribution channel for scaling. mHealth apps still face the problem of monetisation and 55% of apps have less than 5,000 downloads, was mentioned. Full report is freely available here.
In the panel on the state of mHealth apps, with panelists
different reasons for low mHealth apps adoption and user retention were mentioned. An important critical point of apps is that they remind users of their sickness, which can be discouraging for continued use. This is one of the recognised reasons for a lot of B2C apps failing in the last years. A lot of them shifted to B2B2C business models.
Since payments in healthcare are shifting in the direction of outcomes and value based payments, apps are becoming increasingly interesting for Pharma companies offering their patients additional support and value through platforms and apps.
In terms of trends, voice recognition solutions are attracting interest, alongside expectations that app usage will increase with an improved experience provided by solutions coming from big corporations such as Google, Amazon and Apple, which have detailed knowledge about what works in customer engagement which could potentially be translated in to healthcare.
Wednesdays program at the Connected Healthcare Forum at MEDICA Trade Fair, prepared by Future for Health Community, was this years last FTR4H event. Next years roadshow includes presence in USA, India, China and Germany.
The first event in 2018 will be a conference program a SXSW festival, one of the top global tech events, attracting leading tech companies from the US and abroad. We are proud to be a part of it as it presents a valuable opportunity to meet tech savy entrepreneurs from different industries, allowing a step out of the digital health bubble and enabling formation of new ideas for the healthcare space. More information will be published soon. If you’re interested in participating as a company, do not hesitate to contact us!
The FTR4H Talk & Lounge was a combination of an inviting meeting spot – where Startups, Corporates, VCs and other Digital Health aficionados mingled and discussed the Future for Health in a market like China – with a half-day session in the conference forum on the latest developments in Health-Tech.
The partners of the FTR4H Talk & Lounge covered the whole spectrum of the Digital Health Continuum. We had hospitals, researchers, startups and corporates sharing their latest products, services and ideas around how Mobile, IOT, AI and Data are transforming the healthcare sector.
Special focus was put on elderly care with the support of digital solutions, which is a worldwide, not only Chinese challenge. Dr. Junhua Hu, CEO of DARMA INC, a Shenzhen based Digital Health Startup grown up in the famous HAX accelerator ecosystem, rocked the stage with valuable insights and a comparison of the US and Chinese markets.
Sebastien Gaudin from the Shanghai based startup The CareVoice, explained, how close HealthTech and InsureTech are, with demoing the partnership with AXA on the field of a trusted and reliable platform to improve patient experience.
The highlight of our FTR4H inaguration in China was a Fire Side Chat moderated by Mr. Mobile and FTR4H Chief Evangelist, Mark Wächter. All participants agreed, that the Golden Age for Digital Health in China is just beginning.
FTR4H society will be back for sure at Medical Fair China in Suzhou in September 2018!
In the meantime, we will establish a network of digital health movers & shakers in China. We are proud that we won Junhua as our first FTR4H Ambassador in and for this unique market. He will start to extend the FTR4H society now – watch out 🙂
When used for prevention, it has become clear by now, that a person gets tired of using a wearable or a health app in only a few months. It is important to note that this holds true mostly for relatively healthy people, not patients with serious illnesses.
British researcher Prof. Dr. Anthony Turner, Head of The Biosensors and Bioelectronics Centre at Linköping University Sweden: “we haven’t yet made the sensors we really need, we are using the sensors that we happen to have.” That is why in recent years investors have been more interested in other sensors: ingestibles, implantables, etc..
We are entering an era of sensors for complex chemical reactions and molecular recognition in the body. “This requires more regulation and caution in testing and development,” says Prof. Dr. Turner. However, we can expect more significant improvements and outcomes.
Apart from data being questionable due to inconsistent data gathering by the user, another issue is data reliability. If you wear your phone with a tracker and two tracking wearables for activity measurements, you are bound to get different results. Similar is true for home Point of Care devices. Are they then useful or harmful?
If you will ask laboratory technicians, they will tell you that Point of Care devices are far from laboratory accurate. But in which cases is that relevant? As Prof. Dr. Turner says, “from a laboratory perspective and for research purposes you always look for the best. However, Point of Care devices for patients just need to be good enough for managing conditions and early warnings. Personal devices for diabetes are not as accurate as clinical laboratory, but it doesn’t matter – they are good enough for management decision.”
You can listen the whole conversation with prof. dr. Anthony Turner here.
So what can we conclude out of all this? Wearables are simply a step in the evolution of health technology. Sensors are still promising us all a bright future. They bring:
More and more of them are embedded in the environment. Measuring is becoming seamless, taking away the issue of consistency with gathering data.
Biosensors have had a very long and successful history of miniaturization. “It took 20 years for that to happen for wearable blood glucose monitors, while glucose meters evolved from a huge instrument of 40,000 dollars to a device which today costs 7-17 dollars,” illustrates Prof. Dr Turner. For inventors, the biggest issue is, what kind of business model will work. But the final judgement from a financial perspective is clear: massive savings could be achieved.
Want to know more? Tune into the sixth episode of Medicine Today on Digital Health podcast. You can find, listen, subscribe, rate, follow, share the podcast in Soundcloud or in iTunes.
There are currently more than 260,000 mHealth apps on the market, according to data from Research2guidance. Whereas this may be exciting news, the sheer number may also be overwhelming for patients and doctors. How can you know what is useful and what is not? One way hospitals are solving the app reliability challenge is by building in-house innovation incubators.
To get to know how that works, listen to a conversation with Ashish Atreja, the CTO of Sinai AppLab at Mount Sinai, in the fourth episode of Medicine Today on the Digital Health podcast.
He are 5 reasons why in-house innovation incubators are good news.
1. Accelerating change
Innovation arms in hospitals are exciting because they help introduce novelties into the rigid healthcare systems.
2. Providing reliability
New solutions are designed by high profile specialists in hospitals. Consequently, solutions are tested inside the hospitals and perfected before they are put on the market.
“I would never give or prescribe medicine to any of my patients that has not been approved in some formal capacity. Why should I prescribe an app?” says gastroenterologist Ashish Atreja, MD, MPH. If you’re a startup, he might take a look at your solution. Why?
One of his jobs as the CTO of Sinai AppLab is onboarding new technologies built by startups outside Mount Sinai. After all, he emphasizes, “it’s impossible for one incubator to do and know everything.”
3. Ease of recommendation
It is easier for doctors to recommend in-house solutions, because they have better access and understanding of the innovation process and reliability of an app compared to the flood of other mhealth digital health offerings on the market.
As Ashish Atreja explains, Mount Sinai even build a platform which allows physicians to prescribe evidence based apps. “We curate the best apps based on the evidence, security and safety. There’s a whole team of people rating the best apps, looking at the published evidence and bringing them to the market place.”
4. Financial benefit
Innovation arms generate new revenue streams for hospitals.
5. Encouraging innovation
When a support environment for creativity is in place, doctors who want to innovate can test and develop their ideas. They also get all the entrepreneurial support in scaling and improving their ideas, so they can reach patients faster.
In 2012, Cleveland Clinic experts designed the Medical Innovation Playbook – a detailed report on the diverse and rapidly evolving technology commercialisation programs of the USA’s top medical centres. It includes an overview of nearly 10,000 invention disclosures, 6,400 patent applications and almost 2,000 issued patents.
A few weeks ago, the sixth edition of the largest global study on mHealth app has been published by research2guidance, one of the community partners of FTR4H. Its Managing Director, Ralf-Gordon Jahns, is also member of the jury of #5MAC16. In this years report, more than 2,600 mHealth app developers, healthcare professionals shared their experiences and views on the market. Here their most important findings:
“Growth rates of mHealth app store downloads are estimated to be only +7% in 2016 after +35% from the previous year, reaching a total of 3.2B in 2016.”
“US$10 seems to be the threshold for which a patient is willing to pay out-of-pocket for mHealth app services: There is a strong market belief that patients/app users would spent no more than US$10 (or US$9.90) on, for example, a monthly subscription for a health chat, a one-time download of a diet plan or one-time expert feedback. Thresholds vary between service categories but US$10 is the most common.”
“Within the patient journey, follow-up monitoring will be the most influenced phase by mHealth apps: In general, the impact apps will have on the patient journey from seeking information, receiving diagnosis and treatment as well as prevention is rated high. The highest impact is seen on providing follow-up advice and coaching after the initial doctor’s visit.”
Download the complete report here.